Harnessing gene power to make
treatment accessible to all
About AnGes
News
All
Development
Product Info
IR
Information
- 2025.11.25Development
- Notice Regarding Additional Agreement for Co-Developed Tie2 Receptor Agonist (AV-001)
- 2025.11.07Information
- Notice Regarding Establishment of a New R＆D Base in the U.S. by Our Consolidated Subsidiary